Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table 3.1.12 Test<strong>in</strong>g of the Model-b us<strong>in</strong>g the excretion data of occupational workers. The<br />
ratios of the value of function F for the Model-b by the value for ICRP 67 model<br />
are presented for some occupationally exposed <strong>in</strong>dividuals and standard<br />
conditions of exposure to 239 Pu.<br />
Case<br />
code<br />
Number<br />
of data<br />
112<br />
F(Model-b)<br />
F(ICRP 67)<br />
AMAD = 1 µm AMAD = 5 µm<br />
Type M Type S Type M Type S<br />
242 (U) 107 0.97 0.98 0.97 0.98<br />
193 (U) 105 0.91 0.92 0.92 0.93<br />
4 (M) 105 0.94 0.95 0.95 0.96<br />
208 (U) 64 0.97 0.98 0.97 0.98<br />
25 (M) 21 0.99 0.99 0.99 0.99<br />
10 (M) 21 1.05 1.05 1.04 1.05<br />
18 (M) 20 1.36 1.48 1.28 1.41<br />
7 (M) 10 0.96 0.91 0.97 0.91<br />
21 (M) 8 0.83 0.79 0.85 0.81<br />
(U) : case from United States Uranium and Transuranium Registries<br />
(M) : case from Manhattan Project<br />
Although <strong>in</strong>take estimates are not the direct goal of the verification process of this<br />
section, as they were obta<strong>in</strong>ed as by-product of the m<strong>in</strong>imiz<strong>in</strong>g procedure of the function F,<br />
they are here present and commented.<br />
In Table 3.1.13 the <strong>in</strong>takes calculated us<strong>in</strong>g the Model-b are presented with the<br />
percentage deviation from the ICRP 67 estimates for all the standard absorption types (M, S)<br />
and AMADs (1 and 5 µm). The average deviation on all the contam<strong>in</strong>ation cases <strong>in</strong>dicates<br />
that for absorption type M the Model-b and ICRP 67 yield almost the same <strong>in</strong>takes, while for<br />
absorption type S the latter model estimates <strong>in</strong>takes to be smaller by about 10 %. This follows<br />
not only from the ur<strong>in</strong>ary excretion values predicted by the model, but also from the period<br />
when the considered ur<strong>in</strong>e samples were collected (between 1957 and 1997, i.e. 4,400 and<br />
19,000 days post-<strong>in</strong>take). As shown <strong>in</strong> Figure 3.1.19 <strong>in</strong> case of an aerosol of 1 μm AMAD<br />
<strong>in</strong>haled by a forty years old subject, type M, the <strong>Plutonium</strong> ur<strong>in</strong>ary excretion predicted by the<br />
Model-b ranges between –11% and +7% of the ICRP 67 predictions <strong>in</strong> the period of the<br />
samples collection for the considered actual cases of contam<strong>in</strong>ation. Therefore on the average<br />
the f<strong>in</strong>al effect is that both models estimate almost the same <strong>in</strong>takes. In the same period and<br />
under the same condition of exposure, but for absorption S, the <strong>Plutonium</strong> ur<strong>in</strong>ary excretion<br />
predicted by the age related model ranges between –20% and +1% of the ICRP 67<br />
predictions. Therefore the estimations of <strong>in</strong>take based on the Model-b are higher than the<br />
ICRP 67 predictions.